Table 1.
Demographics and results summary. Ratios are expressed as medians, with interquartile ranges.
Rhabdo | APAP all | APAP delayed | P value | |
---|---|---|---|---|
Age | 48 (34–56) | 42 (29–52) | 46 (37–55) | NA |
Male | 115 (71.9%) | 38 (55.9%) | 18 (62%) | NA |
AST/ALT | 1.66 (1.18–2.22) | 1.38 (1.08–1.69) | 1.30 (1.06–1.63) | 0.003396 |
CK/AST | 21.33 (12.75–42.21) | 5.49 (2.52–15.10) | 3.80 (1.43–13.83) | <0.001 |
CK/ALT | 37.06 (16.08–79.95) | 5.77 (2.79–25.18) | 5.03 (2.20–17.36) | <0.001 |
P values represent the results of the Kruskall-Wallis test of comparison between the rhabdomyolysis group and the acetaminophen (delayed) group.
APAP, acetaminophen; rhabdo, rhabdomyolysis; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatine kinase.